Alexza Pharmaceuticals Inc. said Tuesday it entered an agreement with three institutional investors to raise about $16.1 million in a direct offering sale.
Mountain View-based Alexza (NASDAQ:ALXA) said the investors include RA Capital Management and Tavistock Life Sciences.
No comments:
Post a Comment